MARKET

CLVR

CLVR

Clever Leaves Holdings Inc
NASDAQ
4.339
+0.467
+12.05%
Opening 10:53 04/26 EDT
OPEN
3.863
PREV CLOSE
3.872
HIGH
4.430
LOW
3.845
VOLUME
19.37K
TURNOVER
0
52 WEEK HIGH
9.93
52 WEEK LOW
1.716
MARKET CAP
7.61M
P/E (TTM)
-0.3800
1D
5D
1M
3M
1Y
5Y
Cannabis stocks outperform as pressure mount on DEA to reschedule marijuana
Seeking Alpha · 1d ago
Weekly Report: what happened at CLVR last week (0415-0419)?
Weekly Report · 4d ago
Clever Leaves Ends Equity Sales Agreement with Canaccord Genuity
TipRanks · 04/17 21:02
CLEVER LEAVES HOLDINGS- ON APRIL 16, PROVIDED NOTICE TO CANACCORD GENUITY LLC TO TERMINATE CERTAIN EQUITY DISTRIBUTION AGREEMENT, DATED JAN 14, 2022
Reuters · 04/17 20:49
White House says marijuana rescheduling review is now with DOJ
White House says marijuana rescheduling review is now with DOJ. The much-anticipated decision is expected to reclassify cannabis in a low-risk category called Schedule III. Currently, cannabis is included under Schedule I. DEA confirmed the ongoing review in February. White House says it's now up to the Department of Justice to decide.
Seeking Alpha · 04/16 14:13
Weekly Report: what happened at CLVR last week (0408-0412)?
Weekly Report · 04/15 10:52
FDA chief sees no reason for delay in cannabis rescheduling
FDA chief sees no reason for delay in cannabis rescheduling. The DEA is reviewing whether to reschedule marijuana from a high-risk to a low-risk category. A favorable decision will see marijuana move to a Schedule III drug category from its current Schedule I status.
Seeking Alpha · 04/11 19:38
Weekly Report: what happened at CLVR last week (0401-0405)?
Weekly Report · 04/08 10:56
More
About CLVR
Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.

Webull offers Clever Leaves Holdings Inc stock information, including NASDAQ: CLVR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLVR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLVR stock methods without spending real money on the virtual paper trading platform.